Skip to main content

Table 2 MLCR, NLCR, NMCR, and different variables stratified by immune status

From: Evidence for significant influence of host immunity on changes in differential blood count during malaria

 

Semi-immune patients

Non-immune patients

 

Malaria negative N = 5

Malaria positive N = 66

p-value

Malaria negative N = 205

Malaria positive N = 144

p-value

Female, n (%)

4 (80)

21 (32)

 

59 (29)

44 (31)

 

Male, n (%)

1 (20)

45 (68)

.030

146 (71)

100 (69)

.882

Leucocytes /μL

5,900 (4,950; 7,700)

4,900 (3,900; 5,950)

.096

6,000 (5,000; 7,000)

4,850 (3,925; 6,000)

<.001

Monocytes in%,

5 (3; 6)

6 (3; 9)

.315

6 (3; 8)

7 (4; 10)

<.001

/μL

276 (162; 373)

274 (141; 436)

.745

315 (196; 485)

340 (208; 503)

.513

Lymphocytes in%,

36 (24; 54)

32 (22; 38)

.405

34 (27; 41)

22 (14; 32)

<.001

/μL

2,124 ( 1,576; 3,190)

1,325 (989; 2,041)

.059

1,971 (1,563; 2,415)

1,081 (722; 1,542)

<.001

Neutrophils in%,

61 (40; 67)

59 (50; 66)

.857

57 (49; 65)

65 (53; 74)

<.001

/μL

3,082 (2,324; 4,737)

2,880 (1,862; 3,642)

.406

3,306 (2,648; 4,248)

3,006 (2,184; 4,007)

.019

MLCR

0.10 (0.07; 0.21)

0.20 (0.10; 0.32)

.185

0.16 (0.08; 0.22)

0.32 (0.17; 0.52)

<.001

NLCR

1.69 (0.77; 2.83)

1.86 (1.31; 3.19)

.574

1.70 (1.20; 2.40)

2.88 (1.66; 5.19)

<.001

NMCR

11.17 (7.43; 38.75)

9.63 (6.31; 19.33)

.473

10.27 (6.88; 16.81)

8.33 (5.45; 15.90)

.031

Thrombocytes*1000

239 (142; 270)

116 (82; 183)

.024

229 (190; 262)

117 (84; 153)

<.001

/μL

      
 

Uncomplicated malaria, 55/66 (83)

Severe malaria 11/66 (17)

 

Uncomplicated malaria, 117/144 (81)

Severe malaria 27/144 (19)

 

Female, n (%)

17 (31)

4 (36)

 

35 (30)

9 (33)

 

Male, n (%)

38 (69)

7 (64)

.723

82 (70)

18 (67)

.728

Leucocytes /μL

4,900 (3,900; 5,950)

5,800 (4,600; 6,300)

.068

4,700 (3,850; 5,900)

5,400 (4,000; 6,000)

.249

Monocytes in%,

6 (3; 9)

3 (2; 5)

.027

7 (5; 10)

7 (3; 9)

.170

/μL

274 (141; 436)

210 (106; 245)

.126

354 (215; 497)

280 (156; 540)

.364

Lymphocytes in%,

32 (22; 38)

18 (15; 29)

.004

22 (15; 32)

20 (13; 27)

.213

/μL

1,325 (989; 2,041)

1,044 (828; 1,827)

.049

1,113 (718; 1,534)

936 (754; 1,560)

.582

Neutrophils in%,

59 (50; 66)

68 (61; 78)

.006

63 (53; 75)

68 (52; 73)

.732

/μL

2,880 (1,862; 3,642)

3,588 (3,339; 4,914)

.005

3,000 (2,170; 3,944)

3,120 (2,250; 4,144)

.519

MLCR

0.20 (0.10; 0.35)

0.25 (0.09; 0.31)

.925

0.32 (0.19; 0.49)

0.31 (0.15; 0.54)

.526

NLCR

1.86 (1.31; 3.19)

3.83 (2.10; 4.59)

.003

2.76 (1.64; 4.84)

3.40 (2.04; 5.92)

.279

NMCR

8.86 (5.78; 13.33)

23.33 (11.89; 33.38)

.019

8.29 (5.36; 15.00)

9.30 (6.14; 24.08)

.193

Thrombocytes (1000/μL)

116 (82; 183)

92 (59; 111)

.022

124 (93; 163)

100 (51; 118)

.003

  1. Medians (with 25 and 75% percentiles/IQR) of are given if not otherwise mentioned. Ranked means were compared by Mann-Wilcoxon-Whitney test and p-values were presented. P-values <0.05 are marked in bold.
  2. *times.